Advertisement
Screener

ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Net Margin

ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Net Margin

  • 2026-06-30: Net Margin 11.56%.
  • 2026-03-31: Net Margin -10.72%.
  • 2025-12-31: Net Margin 13.64%.
  • 2025-09-30: Net Margin 7.47%.

Complete source-backed net margin history.

Available history
2022-09-30 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-3011.56%
2026-03-31-10.72%
2025-12-3113.64%
2025-09-307.47%
2025-06-30-19.49%
2025-03-31-39.25%
2024-12-31-15.55%
2024-09-30-92.81%
2024-06-30-169.59%
2024-03-31-164.04%
2023-12-31-490.05%
2023-09-30-552.04%
2023-06-30-1488.28%
2023-03-31-2880.26%
2022-12-31-2432.25%
2022-09-30-14856.41%

Annual Net Margin

DateNet Margin
2025-12-31-4.34%
2024-12-31-84.09%
2023-12-31-898.17%
2022-12-31-8449.76%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Arcus Biosciences, Inc. (RCUS)United States$3.188B-8.52
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Organon & Co. (OGN)United States$3.603B17.03
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
PRECIGEN, INC. (PGEN)United States$2.757B-12.94
AbCellera Biologics Inc. (ABCL)$3.879B-14.59